RadNet Reports First Quarter Financial Results and Reaffirms 2012 Full-Year Guidance

FOR IMMEDIATE RELEASE

• Service Fee Revenue, net of contractual allowances and discounts (“Revenue”) was $168.5 million, an increase of 17.0% from $144.1 million in the first quarter of 2011

• Adjusted EBITDA(1) was $29.1  million, an increase of 13.3% from $25.7 million in the prior year’s first quarter; RadNet’s trailing twelve month Adjusted EBITDA(1) rises to $118.9 million

• RadNet substantially narrowed loss in the quarter;  reports essentially breakeven per share earnings compared to a per share loss of $(0.02) in the prior year’s first quarter

• Same Center procedural volumes increased 5.6% as compared with the first quarter of 2011

• RadNet reaffirms 2012 guidance levels 

LOS ANGELES, California, May 10, 2012 – RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 232 owned and/or operated outpatient imaging centers (inclusive of 23 facilities held in Joint Ventures), today reported financial results for its first quarter of 2012.

Financial Results

For the first quarter of 2012, RadNet reported Revenue of $168.5 million, Adjusted EBITDA(1) of $29.1 million and Net Loss of $111,000.  Revenue increased $24.4 million (or 17.0%), Adjusted EBITDA(1) increased $3.4 million (or 13.3%) and Net Loss decreased $765,000, respectively, over the first quarter of 2011.  Per share Net Income for the first quarter was breakeven, compared to a Net Loss of $(0.02) per share in the first quarter of 2011 (based upon a weighted average number of diluted shares outstanding of 37.7 million and 37.3 million for these periods in 2012 and 2011, respectively).  Affecting operating results in the first quarter of 2012 were certain non-cash expenses and non-recurring items including:  $1.2 million of non-cash employee stock compensation expense resulting from the vesting of certain options, restricted stock and warrants; $449,000 of severance paid in connection with headcount reductions related to cost savings initiatives from previously announced acquisitions; $24,000 loss on the sale of certain capital equipment; $771,000 of non-cash Deferred Financing Expense related to the amortization of financing fees paid as part of our existing credit facilities; and $937,000 fair value gain from our interest rate swaps, net of the amortization of  an Accumulated Comprehensive Loss existing prior to April 6, 2010.

For the first quarter of 2012, as compared to the prior year’s first quarter, MRI volume increased 23.8%, CT volume increased 23.0% and PET/CT volume increased 14.6%.  Overall volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 18.9% over the prior year’s first quarter.  On a same-center basis, including only those centers which were part of RadNet for both the first quarters of 2012 and 2011, MRI volume increased 7.5%, CT volume increased 7.3% and PET/CT volume increased 5.8%.  Overall same-center volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 5.6% over the prior year’s same quarter.

Dr. Howard Berger, President and Chief Executive Officer of RadNet, commented “We are pleased with our first quarter results, which show both strong aggregate and same-center Revenue and procedural volume growth.  While our aggregate growth was driven primarily by the CML acquisition completed last November, our organic volume growth of over 5% gives me reason to be optimistic about our operations for the remainder of the year.  Though the first calendar quarter is typically our most challenging quarter due to seasonality from adverse weather and increasing patient participation in higher deductible health plans, our trailing twelve month EBITDA of $118.9 is already approaching the low end of our 2012 guidance levels.”

Dr. Berger continued, “During the first quarter, we continued to execute on our operating plan of enhancing our regional market penetration and presence, driving operational efficiencies and broadening growth opportunities in our existing core markets.  As an example, during the quarter, we announced a joint venture with Barnabus Health, a premier hospital system in New Jersey, designed to deliver a fully integrated imaging network that provides convenient, high quality, cost effective and patient-centric medical imaging solutions for the medical communities of New Jersey.  Additionally, in April, we completed the acquisition of West Coast Radiology, a leading operator of five multimodality facilities in Orange County, CA, which greatly strengthens our footprint in Orange County and enhances our physician capabilities in that region.”

Dr. Berger added, “As we look forward to the coming quarters, we are focused on driving organic volumes, completing additional tuck-in transactions in existing markets, installing the eRAD suite of RIS and PACS in the RadNet network of facilities and establishing further strategic relationships with partners who enhance the number and quality of core market growth opportunities.”
2012 Guidance

RadNet reaffirms its previously announced 2012 fiscal year guidance ranges as follows:

(a) Equivalent to original guidance of $660 million to $700 million as adjusted for the adoption of ASU 2011-07 “Health Care Entities (Topic 954):  Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities”
(b) Net of proceeds from the sale of equipment.
(c) Defined by the Company as Adjusted EBITDA(1) less total capital expenditures and cash paid for interest.

Conference Call for Today

Dr. Howard Berger, President and Chief Executive Officer, and Mark Stolper, Executive Vice President and Chief Financial Officer, will host a conference call to discuss its first quarter 2012 results on Thursday, May 10th, 2012 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Daylight Time).

Conference Call Details:

Date:  Thursday, May 10, 2012
Time:  10:30 a.m. EDT
Dial In-Number:  888-219-1217
International Dial-In Number:  913-312-0720

It is recommended that participants dial in approximately 5 to 10 minutes prior to the start of the 10:30 a.m. call.  There will also be simultaneous and archived webcasts available at http://viavid.net/dce.aspx?sid=00009747 or http://www.radnet.com under the “Investors” menu section and “News Releases” sub-menu of the website.  An archived replay of the call will also be available and can be accessed by dialing 877-870-5176 from the U.S., or 858-384-5517 for international callers, and using the passcode 9486821.

Regulation G: GAAP and Non-GAAP Financial Information:

This release contains certain financial information not reported in accordance with GAAP. The Company uses both GAAP and non-GAAP metrics to measure its financial results.  The Company believes that, in addition to GAAP metrics, these non-GAAP metrics assist the Company in measuring its cash-based performance.  The Company believes this information is useful to investors and other interested parties because it removes unusual and nonrecurring charges that occur in the affected period and provides a basis for measuring the Company's financial condition against other quarters.  Such information should not be considered as a substitute for any measures calculated in accordance with GAAP, and may not be comparable to other similarly titled measures of other companies.  Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP.  Reconciliation of this information to the most comparable GAAP measures is included in this release in the tables which follow.

About RadNet, Inc.
RadNet, Inc. is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of 232 fully-owned and operated outpatient imaging centers.  RadNet’s core markets include California, Maryland, Delaware, Rhode Island, New Jersey and New York.  Together with affiliated radiologists, and inclusive of full-time and per diem employees and technicians, RadNet has a total of approximately 6,300 employees.  For more information, visit http://www.radnet.com.

Forward Looking Statements:

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning successfully integrating acquired operations, successfully achieving 2012 financial guidance, achieving cost savings, successfully developing and integrating new lines of business, continuing to grow its business by generating patient referrals and contracts with radiology practices, and receiving third-party reimbursement for diagnostic imaging services, are forward-looking statements within the meaning of the Safe Harbor. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause the Company's actual results to differ materially from the statements contained herein. Further information on potential risk factors that could affect RadNet's business and its financial results are detailed in its most recent Annual Report on Form 10-K, as filed with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking statements, especially guidance on future financial performance, which speaks only as of the date they are made. RadNet undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.

RadNet, Inc.
Mark Stolper, 310-445-2800
Executive Vice President and Chief Financial Officer

Footnotes
(1) The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, each from continuing operations and adjusted for losses or gains on the sale of equipment, other income or loss, debt extinguishments and non-cash equity compensation.  Adjusted EBITDA includes equity earnings in unconsolidated operations and subtracts allocations of earnings to non-controlling interests in subsidiaries, and is adjusted for non-cash or extraordinary and one-time events taken place during the period.

Adjusted EBITDA is reconciled to its nearest comparable GAAP financial measure.  Adjusted EBITDA is a non-GAAP financial measure used as analytical indicator by RadNet management and the healthcare industry to assess business performance, and is a measure of leverage capacity and ability to service debt.  Adjusted EBITDA should not be considered a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as presented, may not be comparable to other similarly titled measures of other companies.

(2) As noted above, the Company defines Free Cash Flow as Adjusted EBITDA less total Capital Expenditures (whether completed with cash or financed) and Cash Interest paid.  Free Cash Flow is a non-GAAP financial measure.  The Company uses Free Cash Flow because the Company believes it provides useful information for investors and management because it measures our capacity to generate cash from our operating activities. Free Cash Flow does not represent total cash flow since it does not include the cash flows generated by or used in financing activities. In addition, our definition of Free Cash Flow may differ from definitions used by other companies.

Free Cash Flow should not be considered a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as presented, may not be comparable to other similarly titled measures of other companies.